IMMUNOREGULATORY PROFILE OF MICROSYMBIONTS OF THE INTESTINAL HUMAN BIOTOPE
- Authors: Bukharin O.V.1, Chainikova I.N.2, Ivanova E.V.1, Perunova N.B.1, Bondarenko T.A.1, Smolyagin A.I.3
-
Affiliations:
- Institute of Cellular and Intracellular Symbiosis
- Institute of Cellular and Intracellular Symbiosis,Orenburg State Medical University
- Orenburg State Medical University
- Issue: Vol 95, No 4 (2018)
- Pages: 42-51
- Section: ИНФЕКТОЛОГИЧЕСКИЕ МЕХАНИЗМЫ СИМБИОТИЧЕСКИХ ВЗАИМОДЕЙСТВИЙ
- Submitted: 10.04.2019
- Published: 28.08.2018
- URL: https://microbiol.crie.ru/jour/article/view/285
- DOI: https://doi.org/10.36233/0372-9311-2018-4-42-51
- ID: 285
Cite item
Full Text
Abstract
About the authors
O. V. Bukharin
Institute of Cellular and Intracellular Symbiosis
Author for correspondence.
Email: noemail@neicon.ru
Россия
I. N. Chainikova
Institute of Cellular and Intracellular Symbiosis,Orenburg State Medical University
Email: noemail@neicon.ru
Россия
E. V. Ivanova
Institute of Cellular and Intracellular Symbiosis
Email: noemail@neicon.ru
Россия
N. B. Perunova
Institute of Cellular and Intracellular Symbiosis
Email: noemail@neicon.ru
Россия
T. A. Bondarenko
Institute of Cellular and Intracellular Symbiosis
Email: noemail@neicon.ru
Россия
A. I. Smolyagin
Orenburg State Medical University
Email: noemail@neicon.ru
Россия
References
- Гапон М.Н., Терновская Л.Н., Денисенко О.В., Зарубинский В.Я. Показатели иммунитета и локальной защиты у людей с дисбактериозом кишечника. Журн. микробиол. 2014, 4: 65-68.
- Зорина В.В., Николаева Т.Н., Наровлянский А.Н. Влияние бактерий рода Lactobacillus на продукцию цитокинов клетками пейеровых бляшек экспериментальных животных. Иммунология, 2004, 5: 288-290.
- Carvalho R.D.D.O., do Carmo F.L.R., de Oliveira Junior A. et al. Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis. Frontiers in Microbiology. 2017, 8:800. doi: 10.3389/fmicb.2017.00800.
- de Moreno de LeBlanc A., Del Carmen S., Chatel J.M.et al. Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models. Gastroenterol. Res. Pract. 2015:146972. doi: 10.1155/2015/146972.
- Kim D., Ybo S.A., Kim W.U. Gutmicrobiota in autoimmunity: potential for clinical applications. Arch Pharm Res. 2016, 39 (11): 1565-1576.
- Kim D., Zeng M.Y., Nunez G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Experimental Molecular Medicine. 2017, 49(5): e339-. doi: 10.1038/emm.2017.24.
- Koh A., De Vadder F., Kovatcheva-Datchary P., Backhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016,165: 1332-1345.
- Lee S.H., Kwon J., Cho M.-L. Immunological pathogenesis of inflammatory bowel disease. Intestinal Research. 2018, 16 (1): 26-42.
- Levy M., Kolodziejczyk A.A., Thaiss C.A., Elinav E. Dysbiosis and the immune system. Nat. Rev. Immunol. 2017, 17 (4): 219-232.
- Lin L., Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunology. 2017, 18:2. doi: 10.1186/s12865-016-0187-3.
- Llewellyn A., Foey A. Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events. Nutrients. 2017, 9 (10): 1156. doi: 10.3390/nu9101156.
- Mowat A.M., Bain C.C. Mucosal Macrophages in Intestinal Homeostasis and Inflammation. Journal of Innate Immunity. 2011, 3 (6): 550-564.
- Nakase H., Okazaki K., Tabata Yet al. New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2002, 301 (1): 59-65.
- Pagliari D., Gambassi G., Piccirillo C.A. et al. The Intricate Link among Gut Immunological Niche, Microbiota, and Xenobiotics in Intestinal Pathology. Mediators of Inflammation. 2017:8390595. doi: 10.1155/2017/8390595.